Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

DexCom, Inc. DXCM

Healthcare  —  Medical Devices
86.62 (0.85) (0.97%) as of 25 Sep
Market cap
$33.0B
P/E
33.4×
S&P 500 Member Cash Flow Champion (3y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio 26.00 26.17 30.87 36.37

+8 more quarters
P/S ratio 5.18 5.02 5.56 5.83
P/FCF ratio 18.32 16.92 24.04 24.78
P/Operating CF 95.62 46.01 88.09 39.88
P/B ratio 9.82 8.18 9.43 9.65
Price to Tangible BV 10.31 8.43 9.77 10.03
EV/Sales 5.07 4.81 5.42 5.40
EV/EBITDA 17.95 17.92 21.73 23.85
EV/Operating CF 14.40 12.99 17.55 16.84
EV/FCF 17.92 16.20 23.47 22.96
Quick Ratio 1.36 1.58 1.50 1.33
Current Ratio 1.73 1.95 1.88 1.56
Net Debt/EBITDA (1.82) (3.64) (1.95) (6.80)
Debt/Assets 19.25% 18.72% 19.57% 16.53%
Debt/Equity 0.47 0.42 0.45 0.45
Asset Turnover 0.72 0.72 0.73 0.65
Operating CF/Net income 1.08 2.63 1.10 2.33
Capex/Depreciation (1.24) (1.14) (1.56) (1.27)
Interest Coverage 0.00 0.00 0.00 0.00
Research and Development Expense of Revenue 11.69% 12.19% 11.77% 13.02%
Selling, General and Administrative Expense of Revenue 27.42% 29.34% 25.52% 27.40%
Intangible Assets out of Total Assets 0.02 0.01 0.02 0.01
Share Based Compensation of Revenue 2.98% 3.63% 2.78% 3.73%
Graham Net Nets 0.01 0.03 0.02 0.02
Graham Number 19.99 20.36 18.45 17.03
Earnings Yield 3.85% 3.82% 3.24% 2.75%
Free Cash Flow Yield 5.46% 5.91% 4.16% 4.04%
Revenue per Share 3.42 3.10 3.23 3.09
Operating CF per Share 0.70 1.36 0.75 1.69
Capex per Share (0.22) (0.20) (0.26) (0.21)
Free Cash Flow per Share 0.48 1.17 0.49 1.48
Cash per Share 5.09 6.27 5.12 8.49
Shareholders Equity per Share 6.86 7.68 7.04 6.97
Interest Debt per Share 0.00 0.00 0.00 0.00
Book value per Share 6.86 7.68 7.04 6.97
Free Cash Flow 184.50 449.00 192.10 579.40
Working Capital 1,728.90 2,107.90 1,890.80 1,883.50
Capital Expenditures (84.70) (76.60) (101.90) (80.50)
Net Current Asset Value 252.70 655.30 439.40 445.60
EV/EBIT 22.11 22.41 27.73 31.35
Capex to Sales 0.06 0.06 0.08 0.07
Net Profit Margin 19.04% 16.74% 21.22% 23.47%
Price to Operating Income 22.60 23.40 28.40 33.84
Other line items
Average Receivables 1,303.25 1,121.90 1,110.90 1,055.80
Average Payables 2,067.65 1,882.25 1,764.55 1,762.45
Average Inventory 648.55 615.90 585.85 595.20
Average Assets 6,891.15 6,692.50 6,412.20 6,926.90
Average Common Equity 2,597.25 2,611.75 2,424.30 2,352.55

Fold the line items

Columns are period end dates